Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CPRX > SEC Filings for CPRX > Form 8-K on 4-Mar-2014All Recent SEC Filings

Show all filings for CATALYST PHARMACEUTICAL PARTNERS, INC.

Form 8-K for CATALYST PHARMACEUTICAL PARTNERS, INC.


4-Mar-2014

Change in Directors or Principal Officers, Regulation FD D


Item 5.02(e) Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On February 27, 2014, the Company's Board of Directors approved the adoption of the "Catalyst Pharmaceutical Partners, Inc. 2014 Stock Incentive Plan" (the "2014 Plan"). The 2014 Plan will not become effective until the 2014 Plan is approved by the Company's stockholders, and the Company expects to submit the 2014 Plan to its stockholders for approval at the Company's 2014 Annual Meeting of Stockholders.

A copy of the 2014 Plan as adopted by the Board of Directors is attached hereto as Exhibit 10.1.



Item 7.01 Regulation FD Disclosure

On February 27, 2014, the Board of Directors adopted the Second Amended and Restated Charter of the Audit Committee of the Company, the Amended and Restated Charter of the Compensation Committee of the Company, and the Second Amended and Restated Charter of the Nominating and Corporate Governance Committee of the Company. The amended and restated committee charters have been posted to the Company's investor relations website and are available at http://ir.catalystpharma.com/governance.cfm.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

10.1 Catalyst Pharmaceutical Partners, Inc. 2014 Stock Incentive Plan


  Add CPRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CPRX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.